This medical condition has either been superseded or has become inactive
| Specific Conditions |
|
| Level of Evidence | Insufficient data (Category 4a) |
|
Intravenous immunoglobulin (IVIg) may be considered in exceptional circumstances for intractable pain or progressive muscle weakness in patients in whom steroids are ineffective or cannot be tolerated. This condition is monophasic and usually self-limiting. A single treatment may be sufficient, although monthly infusions for up to six months may be required for recurrent pain. Refer to the current product information sheet for further information. The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient. |
|